Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Embody deserves consideration for its straightforward monthly headline. I would resolve the supplied quantity and refund calculation before paying; those details matter more than the price-lock slogan.

$99/month advertised injection planInjection offer; confirm quantity and renewal details
InjectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Product-specific $99 monthly price published
  • Clinical partner and possible pharmacies identified
  • Messaging and follow-ups advertised

What to weigh

  • Vial quantity and concentration not established by reviewed offer
  • Cancellation requests need at least 72 hours before renewal
  • Medical-disqualification refunds can deduct services already used

The appeal is a price you can understand

Embody’s dedicated sermorelin page advertises an injection at $99 per month, with provider review, prescribing if appropriate, telemedicine and shipping included. It presents the offer as a fall promotion with an ongoing price lock. That is a simpler starting point than a low monthly equivalent attached to a long prepayment.

I would still ask for the precise supply, renewal date, and charge before deciding it is the better purchase. Two services can show the same monthly amount while dispensing different quantities or including different care. Without those details, the comparison stops at the headline.

Embody’s reviewed offer does not establish the vial quantity and concentration. That gap is more consequential than the many benefit claims on the page: it prevents a reader from understanding exactly what the recurring purchase contains.

Read the cancellation rule before the price lock

The linked August 2026 policy requires cancellation at least 72 hours before the next billing date. Payments are generally final from purchase, and cancellation stops future charges rather than returning money already paid.

The medical-disqualification exception is also narrower than a casual reading of the landing-page refund message might suggest. The policy allows deductions for services already rendered, including clinician review. Ask what refund would apply if you are not prescribed treatment.

Three questions before paying
QuestionWhy it matters
When is my next charge?You need time to meet the 72-hour notice requirement.
What amount is refundable if I am ineligible?The policy permits deductions for services already used.
What happens if I cancel after paying?Stopping renewal does not reverse an existing payment.

My view is that the policy deserves the same prominence as the price. A low monthly commitment can still be an unforgiving purchase if you change your mind after paying or miss the cancellation window.

Knowing the clinical network is useful

The offer identifies OpenLoop Health in its description of clinical evaluation and lists several possible pharmacy partners. That gives a reader a more concrete starting point than an unnamed “medical team.” The terms distinguish the technology platform from the independent clinicians and pharmacies.

A partner list does not identify the pharmacy assigned to your prescription. Ask for that name and contact information, then check the relevant licensing record. Likewise, learn who is treating you and how to reach that person when a medication question arises.

I would use the published names to ask better questions, not to award a blanket quality badge. This review has not inspected clinical records or audited the dispensing process. A provider’s description of its network is evidence about what it publishes, not a measurement of every patient’s care.

Low-friction intake is not a monitoring plan

The page promotes getting started without required bloodwork and advertises messaging and follow-ups. That may sound convenient, but convenience alone does not establish whether testing is appropriate for you. Ask the clinician how your medical history affects the evaluation and which findings would change the recommendation.

Before agreeing to ongoing treatment, identify the problem you are trying to address and how improvement will be assessed. An increase in a hormone marker, better sleep, and improved physical function are different outcomes. A broad promise about vitality does not specify which one the plan will measure.

Read our IGF-1 guide for the distinction between diagnosis, biological response, and benefit. Do not use either a promotional statement or this review to design your own testing or medication schedule.

My assessment of the tradeoff

Embody is most worth considering when a short recurring purchase and a published price are priorities. It becomes less compelling if you need a forgiving refund policy or a fully specified medication offer before checkout. The deciding answers are the supplied quantity, the clinical plan, and the financial consequences of ineligibility or stopping.

Ask for those answers together in writing. Also confirm availability in your state; the general terms direct prospective patients to support for current availability. A national-looking storefront does not settle product-specific access.

We reviewed public information and did not enroll, purchase or use medication. Compounded sermorelin is not FDA-approved, and naming a facility or clinical network does not change that. See the regulatory explanation and the wider comparison before selecting a service.

Common questions

Does cancel anytime mean a refund?

No. The linked policy says cancellation stops future billing, requires at least 72 hours before the next billing date, and generally does not refund payments already made.

Is a refund guaranteed if I am not eligible?

The policy allows a medical-disqualification refund for the unused portion, with deductions for services already rendered. Ask what that would mean for your order.

Explore Embody

See the current offer and decide whether you want to start a consultation.

Visit Embody

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Sources reviewed October 2026. Provider prices and terms may change.

  1. Embody website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement